Navigation Links
BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards
Date:10/1/2007

NAAS, Ireland, Oct. 1 /PRNewswire/ -- A highly sensitive, easy-to-use test that accurately detects bovine viral diarrhea virus (BVDV) was selected as the Best New Veterinary Product for Diagnostics in the annual Animal Pharm Awards. BoVir(R) BVDV real time PCR test was selected for its excellence and innovation by an independent judging panel representing members of the global community of animal sciences practitioners and professionals. The award was presented September 25, 2007, during a black-tie ceremony at Gibson Hall, London, UK.

The newly available BVDV test was developed by AnDiaTec GmbH of Germany, and is distributed globally by Enfer Diagnostics. According to Animal Pharm, the worldwide news service for the animal health industries and sponsor of the competition, "the panel of judges believed that BoVir made eradication of BVDV a realistic option for cattle producers."

"We are very pleased that BoVir(R) has been recognized as a diagnostic test that provides veterinarians, laboratories, and herd managers with an accurate, one-step, and cost-effective solution for successful BVDV eradication," said AnDiaTec developmental geneticist and company owner, Dr. Johannes Kehle upon accepting the award. "Now a farmer can be sure that BVDV detection is early, accurate, and reliable."

According to the judges, BoVir(R) was selected as best in the diagnostic category for its ability to address the four key issues that make current BVDV detection problematic -- the test is easy to use, it's highly sensitive and specific, it provides unprecedented early detection of the virus, and it produces the most advanced genotype and strain diversity detection.

"Our unique, proprietary lysis buffer eliminates the need for the costly, labor-intensive, and time-consuming RNA extraction step, which further eliminates the complicated error-prone steps often associated with inhibiting high throughput molecular labs," said Dr. Kehle. "In addition, BoVir(R)'s ability to detect all 68 referenced strains provides the vet lab, veterinarian, and farmer the confidence that positives will be detected and that negatives are actually negatives."

The award acceptance by AnDiaTec and Enfer Diagnostics was followed by a September 26, 2007, grand opening celebration of the new Enfer Diagnostics Research and Operations Center in Naas, Ireland. The 50,000 square-foot vet diagnostics manufacturing, logistics, customer training, customer service and operations center also provides services focused on vet diagnostic research and development, European and global technical support, lab process integration testing and validation, and lab diagnostic training. The center also serves as an industry partner alignment center and expects to employ over 300 workers within the next 24 to 30 months.

"Enfer Diagnostics is committed to exceeding the needs of the large animal producer and the veterinary diagnostic laboratories with our world-class Enfer Diagnostics Research and Operations Center," stated Cliff Cain, Enfer Diagnostics President. "Animal Pharm's independent review and subsequent 2007 New Product of the Year award validates our decision to bring state-of-the-art molecular diagnostic products for use in large-animal production operations."

More than 200 local, national, and international dignitaries attended the grand opening, including key veterinary opinion leaders and Ireland's Prime Minister Bertie Ahearn.

AnDiaTec GmbH & Co. (http://www.andiatec.com) is a privately held company located near Stuttgart, Germany. The company specializes in unique and proprietary reagents for use in human and veterinary diagnostics and detection systems, and performs environmental analytics under commercial lab services.

Headquartered in Naas, Ireland, Enfer Diagnostics (http://www.enferdiagnostics.com) is a specialized provider of advanced diagnostics to improve animal disease management worldwide. Enfer is the first biotechnology company worldwide to develop a rapid test screening system for bovine spongiform encephalopathy (BSE). Recognized by industry and working to observe the needs of government agencies, Enfer Diagnostics is committed to delivering only the most accurate diagnostics that disease eradication demands. Its worldwide diagnostics distribution also includes BSE screening, and ParaTub(R), an automated, high throughput test for the detection of Mycobacterium paratuberculosis (Johne's disease), an incurable cattle infection impacting the beef and dairy cattle industry.

For more information on the annual Animal Pharm awards, visit http://www.animalpharmawards.com.


'/>"/>
SOURCE Enfer Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Bruce Maas named CIO at UW-Milwaukee
2. Three finalists named for UW-Madison CIO
3. Eight lawmakers named to Speakers IT task force
4. Hospital named for Madame Curie installs TomoTherapy system
5. Two UW-Madison professors named to National LambdaRail Networking Research Council
6. UW researcher named top innovator
7. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
8. Inacom named Microsofts favorite learning solutions partner of the year
9. Five Wisconsin CIOs named top in nation
10. Deltanoid named to top-15 list of biotech companies
11. Roche Diagnostics Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" ... clinical data from its phase 1/2 tendon repair study investigating ... (RCT-01) as a treatment for Achilles tendinosis. ... The clinical trial ... 6 months and showed no serious adverse events related to ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... fight against cancer, autoimmune disease and more through a single-cell precision engineering platform, ... proteomics analysis platform developed in the laboratory of Dr. James Heath at ...
(Date:3/27/2017)... , March 27, 2017  The global ... for 2016, according to a new report from ... lab testing is performed to evaluate disease progression, ... therapy, among other reasons.  The healthcare market research ... , provides an overview of the medical ...
(Date:3/27/2017)... ... March 27, 2017 , ... A research team ... vascular grafts in JoVE’s Video Journal, the world’s first peer-reviewed scientific video journal. ... of treating coronary artery disease (CAD). Lam is an assistant professor at the ...
Breaking Biology Technology:
(Date:3/2/2017)... March 2, 2017 Australian stem cell and ... CYP), has signed an agreement with the Monash Lung ... Biomedicine Discovery Institute and Department of Pharmacology at Monash ... further preclinical study to support the use of Cymerus™ ... Asthma is a chronic, long term ...
(Date:2/28/2017)... Feb. 28, 2017   Acuant , a leading ... announces significant enhancements to new and core technologies building ... products include mobile and desktop Acuant FRM TM ... - a real time manual review of identity documents ... provides the fastest and most accurate capture software to ...
(Date:2/28/2017)... Spanien, 27. Februar 2017  EyeLock LLC, ein marktführendes ... seine erstklassige biometrische Lösung zur Iris-Erkennung auf ... X16 LTE auf dem Mobile World Congress ... Qualcomm-Stand in Halle 3, Stand 3E10, vorstellen. ... Sicherheitsplattform Qualcomm Haven™ – eine Kombination aus ...
Breaking Biology News(10 mins):